TBPH
Price
$12.42
Change
+$0.50 (+4.19%)
Updated
Aug 13 closing price
Capitalization
625.97M
83 days until earnings call
VIGL
Price
$8.05
Change
-$0.00 (-0.00%)
Updated
Aug 4 closing price
Capitalization
375.71M
85 days until earnings call
Interact to see
Advertisement

TBPH vs VIGL

Header iconTBPH vs VIGL Comparison
Open Charts TBPH vs VIGLBanner chart's image
Theravance Biopharma
Price$12.42
Change+$0.50 (+4.19%)
Volume$645.68K
Capitalization625.97M
Vigil Neuroscience
Price$8.05
Change-$0.00 (-0.00%)
Volume$5.51M
Capitalization375.71M
TBPH vs VIGL Comparison Chart in %
Loading...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TBPH vs. VIGL commentary
Aug 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TBPH is a Buy and VIGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 14, 2025
Stock price -- (TBPH: $12.42 vs. VIGL: $8.05)
Brand notoriety: TBPH and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TBPH: 326% vs. VIGL: 301%
Market capitalization -- TBPH: $625.97M vs. VIGL: $375.71M
TBPH [@Biotechnology] is valued at $625.97M. VIGL’s [@Biotechnology] market capitalization is $375.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.51B to $0. The average market capitalization across the [@Biotechnology] industry is $1.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TBPH’s FA Score shows that 0 FA rating(s) are green whileVIGL’s FA Score has 0 green FA rating(s).

  • TBPH’s FA Score: 0 green, 5 red.
  • VIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, TBPH is a better buy in the long-term than VIGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TBPH’s TA Score shows that 4 TA indicator(s) are bullish while VIGL’s TA Score has 3 bullish TA indicator(s).

  • TBPH’s TA Score: 4 bullish, 4 bearish.
  • VIGL’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, TBPH is a better buy in the short-term than VIGL.

Price Growth

TBPH (@Biotechnology) experienced а +11.09% price change this week, while VIGL (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +14.81%. For the same industry, the average monthly price growth was +26.20%, and the average quarterly price growth was +20.07%.

Reported Earning Dates

TBPH is expected to report earnings on Nov 05, 2025.

VIGL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+14.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TBPH($626M) has a higher market cap than VIGL($376M). VIGL YTD gains are higher at: 373.529 vs. TBPH (31.987). TBPH has higher annual earnings (EBITDA): -42.3M vs. VIGL (-91.27M). TBPH has more cash in the bank: 131M vs. VIGL (87.1M). VIGL has less debt than TBPH: VIGL (12.7M) vs TBPH (48.2M). TBPH has higher revenues than VIGL: TBPH (65.3M) vs VIGL (0).
TBPHVIGLTBPH / VIGL
Capitalization626M376M166%
EBITDA-42.3M-91.27M46%
Gain YTD31.987373.5299%
P/E Ratio51.75N/A-
Revenue65.3M0-
Total Cash131M87.1M150%
Total Debt48.2M12.7M380%
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TBPHVIGL
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend about 1 month ago
87%
Declines
ODDS (%)
Bearish Trend 20 days ago
73%
Bearish Trend 14 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 3 days ago
68%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CUSCX11.930.46
+4.01%
Cullen Small Cap Value C
IRCIX12.14N/A
N/A
Voya Russell Small Cap Index Port S2
PFRSX28.02N/A
N/A
Principal Real Estate Securities Fd R6
TLACX12.27N/A
N/A
Transamerica Large Core ESG A
GABIX49.67N/A
N/A
Gabelli Asset I

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
+4.19%
KYMR - TBPH
40%
Loosely correlated
+2.16%
ELEV - TBPH
38%
Loosely correlated
N/A
IMCR - TBPH
35%
Loosely correlated
+3.55%
AXON - TBPH
34%
Loosely correlated
-0.40%
ARRY - TBPH
34%
Loosely correlated
+6.76%
More